Table 2 Anti-malarial drugs used as second-line treatment by medical practitioners
Drugs prescribed by 132 clinicians | Adults N= 124 (%) | Pregnant women n = 113 (%) | Under five children N= 122 (%) |
|---|---|---|---|
Injectable quinine | 43.2 | 53.7 | 36.4 |
Injectable Artemether | 3.0 | 1.5 | 3.8 |
AS/AQ | 2.3 | 3.0 | 2.3 |
Artesunate-mefloquine | 9.8 | 0.8 | 3.8 |
Artemether-lumefantrine | 3.0 | 0.0 | 0.8 |
Quinine (oral) | 20.4 | 19.7 | 13.6 |
Amodiaquine | 0.8 | 1.5 | 6.0 |
Artesunate suppositories | 10.6 | 5.3 | 18.1 |
Dihydroartemisinin | 3.0 | 7.6 | 10.6 |
Artemether, oral | 0.0 | 1.5 | 2.3 |
Halofantrine | 0.8 | 0.0 | 0.0 |
Injectable Sulphadoxine/Pyrimethamine | 2.3 | 3.8 | 1.5 |
Sulphadoxine/Pyrimethamine | 0.0 | 0.8 | 0.0 |
Quinine + antibiotics | 0.0 | 0.8 | 0.8 |